Axess4you – Save Time, Optimize Decision Making, Improve Patients Outcomes
Country Pricing & Reimbursement (P&R) Processes are complex, time consuming and inefficient: Pharma and Medical Devices companies struggle to prepare meaningful value dossiers based on trustable data and achieve their price targets, while spending significant amount of time to prepare their country negotiation strategies.
- The average time to market access for a new drug in Italy is around 14 months
- Price Negotiations with decision makers are often not based on Real World Data & Technology Value
- Due to industry premium price targets, many patients may never be able to get access to innovations
- NHS Systems are unable to cope with Exabyte of data, and cannot interrelate technologies data
Steps | Log in -> Vote project -> Vote now -> Confirm Vote -> Be BOLD